{
  "id": 3531243,
  "title": "Is It Too Late to Buy Eli Lilly? Billionaire Ken Griffin Doesn't Think So. He Nearly Quadrupled His Stake in the Pharma Stock in Q2.",
  "url": "https://urgent.news/2026/08/26/is-it-too-late-to-buy-eli-lilly-billionaire-ken-griffin-doesnt-think",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-08-26T15:05:00.000Z",
  "source": {
    "name": "Nasdaq Markets",
    "slug": "nasdaq-markets",
    "url": "https://www.nasdaq.com/articles/it-too-late-buy-eli-lilly-billionaire-ken-griffin-doesnt-think-so-he-nearly-quadrupled-his"
  },
  "original_language": "en",
  "account": null,
  "summary": "Key PointsObesity drugs like Mounjaro and Zepbound could help the drugmaker power ahead for years.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}